Women with osteoporosis have at least a 50% chance of reaching their target bone mineral density at 3 years if they have a BMD T-score of at least –2.8 at the total hip or –3.1 at the lumbar ...

Among women who received alendronate in the ACTIVExtend trial, a 50% or greater likelihood for achieving a total hip BMD T-score of more than –2.5 was seen with a baseline T-score as low as –2 ...

The probability of achieving total hip T-scores greater than -2.5 increased with treatment duration. After 1 year of treatment, this probability was 37% among women with baseline total hip T ...